Identification of Risk Factors for Diabetes Type 2 and Components of Pharmacists' Interventions in Community Pharmacy Setting: A Serbian Pilot Study

被引:1
|
作者
Tasic, Ljiljana [1 ]
Pesic, Vukica Kocic [2 ]
机构
[1] Univ Belgrade, Fac Pharm, Dept Social Pharm & Pharmaceut Legislat, V Stepe Str 450, Belgrade 11221, Serbia
[2] ADOC Co, Dept Res & Qual, Belgrade, Serbia
关键词
Prevention; Type 2 Diabetes Mellitus; Pharmacists' Intervention; Complex intervention; Community Pharmacy; SYSTEMATIC REVIEWS; PROGRAM; IMPACT; CARE; MANAGEMENT; SERVICES; GLUCOSE;
D O I
10.5530/ijper.50.1.12
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Prevention of Type 2 diabetes (T2D) is clinical service useful to implement on community pharmacy settings (CP). The objectives of study were: to determine the risk factors for T2D in adults visiting a community pharmacy; to determine and describe component of pharmacists' interventions (PI) focusing on feasibility of complex intervention (CI). A cross-sectional study design and conducted (January 2010 to June 2011) on 20 CP in Serbia. Adult population was enrolled (304 patients). The pharmacist trained for implementation of complex PI (screening and counseling session). The national Questionnaire for T2D risk estimation was used for screening and Intervention check list was design and used for process of counseling. The DEPICT (Descriptive Elements of Pharmacist Intervention Characterization Tool) was used to describe the component of CI. High and very high risk score was estimated in age group 45-54 (10.80%) forward in age group 55-64 (9.60%); into the cohort below 45 year the 59 adults has low T2D risk score. The average value of PI/per patients was 4.02. From the eight domain/component (operational descriptor in DEPICT) the main component are 'education and counseling' with four type (items) of intervention performed in counseling session. As a conclusion, the pharmacists in CP detected and scoring risk of T2D in Serbian adults' population. The number and type of PI in counseling session adequate to participants clinical profile. Feasibility of the CI within the CP in Serbia was proved. For the outcomes measurements and impact of PI, a proper endpoint and follow-up study design should be conduct.
引用
收藏
页码:90 / 102
页数:13
相关论文
共 50 条
  • [1] Know your diabetes risk project: Student pharmacists educating adults about diabetes risk in a community pharmacy setting
    Letassy, Nancy
    Dennis, Vincent
    Lyons, Timothy J.
    Harrison, Don
    Burton, Michael
    Kirkpatrick, Alice
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2010, 50 (02) : 188 - U100
  • [2] A Pilot Study Evaluating Multiple Risk Factor Interventions by Community Pharmacists to Prevent Cardiovascular Disease: The PAART CVD Pilot Project
    McNamara, Kevin P.
    O'Reilly, Sharleen L.
    Dunbar, James A.
    Bailey, Michael J.
    George, Johnson
    Peterson, Gregory M.
    Jackson, Shane L.
    Janus, Edward D.
    Bunker, Stephen
    Duncan, Gregory
    Howarth, Helen
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (02) : 183 - 191
  • [3] The Effectiveness of Screening for Diabetes and Cardiovascular Disease Risk Factors in a Community Pharmacy Setting
    Willis, Andrew
    Rivers, Peter
    Gray, Laura J.
    Davies, Melanie
    Khunti, Kamlesh
    PLOS ONE, 2014, 9 (04):
  • [4] Enhancing health care for type 2 diabetes in Northern Brazil: A pilot study of pharmaceutical care in community pharmacy
    Balisa-Rocha, Blicie Jennifer
    Guimaraes, Viviane Gibara
    Mesquita, Alessandra Rezende
    Aguiar, Patricia Melo
    Krass, Ines
    de Lyra, Divaldo Pereira, Jr.
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 6 (35): : 2584 - 2591
  • [5] A pilot study of Pharmacist-Dietician Collaborative support and Advice (PDCA) for patients with type 2 diabetes in community pharmacy: A single-arm, pre-post study
    Shoji, Masaki
    Sakane, Naoki
    Ito, Naoki
    Sunayama, Keiji
    Onda, Mitsuko
    PHARMACY PRACTICE-GRANADA, 2022, 20 (02):
  • [6] An evaluation of community pharmacy-based services for type 2 diabetes in an Indonesian setting: patient survey
    Wibowo, Yosi
    Parsons, Richard
    Sunderland, Bruce
    Hughes, Jeffery
    PEERJ, 2015, 3
  • [7] Classification and identification of risk factors for type 2 diabetes
    Tang, Shan-Shan
    Zhao, Xue-Fei
    An, Xue-Dong
    Sun, Wen-Jie
    Kang, Xiao-Min
    Sun, Yu-Ting
    Jiang, Lin-Lin
    Gao, Qing
    Li, Ze-Hua
    Ji, Hang-Yu
    Lian, Feng-Mei
    WORLD JOURNAL OF DIABETES, 2025, 16 (02)
  • [8] A systematic review exploring characteristics of lifestyle modification interventions in newly diagnosed type 2 diabetes for delivery in community pharmacy
    Katangwe, Thando
    Bhattacharya, Debi
    Twigg, Michael J.
    INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2019, 27 (01) : 3 - 16
  • [9] Determining type 2 diabetes risk factors for the adults: A community based study from Turkey
    Cosansu, Gulhan
    Celik, Seyda
    Ozcan, Seyda
    Olgun, Nermin
    Yildirim, Nurdan
    Demir, Hulya Gulyuz
    PRIMARY CARE DIABETES, 2018, 12 (05) : 409 - 415
  • [10] Assessment of a screening protocol for type 2 diabetes in community pharmacy. The DiabNow Study
    Fikri-Benbrahim, Narjis
    Martinez-Martinez, Fernando
    Saez-Benito, Loreto
    Suarez Luque, Blanca
    Garcia Corpas, Jose Pedro
    Moullin, Joanna C.
    Sabater-Hernandez, Daniel
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 108 (03) : E49 - E52